Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Halopemide is a potent inhibitor of phospholipase D (PLD), inhibiting human PLD1 and PLD2 in vitro (IC50 = 220 and 310 nM, respectively) and PLD activity in cells.1 Previously, halopemide has been found to inhibit dopamine receptors and was evaluated as a neuroleptic agent.2
WARNING This product is not for human or veterinary use.
1. Design of isoform-
2. Selectivity of agonists and antagonists at D2 dopamine receptors compared to D1 and S2 receptors. Drug Dev. Res. 9, 63-69 (1986).
Free fatty acids inhibit serum deprivation-